HIS
IMVT icon

Harvest Investment Services’s Immunovant IMVT Stock Holding History

Harvest Investment Services’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25,305
Closed -$392K – 173
2023
Q1 		$392K Sell
25,305
-2,576
-9% -$44.7K 0.3% 76
2022
Q4 		$495K Buy
+27,881
New +$351K 0.53% 62

Other funds holding IMVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Harvest Investment Services's IMVT Position: Q2 2023 in Review

Harvest Investment Services sold out of Immunovant (IMVT) in Q2 2023, closing a stake of 25,305 shares — an estimated $392K sold.

Harvest Investment Services first reported a position in IMVT in Q4 2022 and held it in 2 quarters. The position peaked at $495K in Q4 2022. 147 funds tracked by Wall St. Rank hold IMVT as of Q2 2023.

  • Harvest Investment Services reported no remaining Immunovant position as of Q2 2023 after selling out during the quarter.
  • Harvest Investment Services sold 25,305 Immunovant shares in Q2 2023, an estimated $392K.
  • Harvest Investment Services first reported a position in Immunovant in Q4 2022 and held it in 2 quarters.
  • Harvest Investment Services's Immunovant position peaked at $495K in Q4 2022.
  • 147 funds tracked by Wall St. Rank held Immunovant as of Q2 2023.

Based on Harvest Investment Services's 13F filing for Q2 2023, filed 11 Aug 2023.